Sort
39,280 grants matching “leukemia”
Mechanism of EVI1-induced Leukemogenesis
$320,822Archibald S Perkins · University Of Rochester · R01 · FY2010 · CA
Colorectal Cancer
$320,795Mark J Ratain · University Of Chicago · U01 · FY2008 · GM
B-cell repertoires in chronic lymphocytic leukemia
$320,773Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2010 · CA
B-cell repertoires in chronic lymphocytic leukemia
$320,773Nicholas Chiorazzi · Feinstein Institute For Medical Research · R01 · FY2009 · CA
Genomic Profiling of Childhood de novo and Relapsed AML
$320,760Stanford University · R01 · FY2001 · CA
Induction of Donor Tolerance in Renal Transplants
$320,733Regenerex, Llc · R41 · FY2005 · DK
Project 5: Transplant Conditioning for MDS and AML with Biological Agents
$320,732Judith Anne Shizuru · Stanford University · P01 · FY2022 · CA
Hematopoietic Stem Cells for Transplantation
$320,731Johns Hopkins University · P01 · FY2005 · CA
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia
$320,692Iannis Aifantis · New York University School Of Medicine · R01 · FY2013 · CA
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
$320,666Ulf Klein · Columbia University Health Sciences · R01 · FY2014 · CA
Computer-assisted Grading and Risk Stratification of Follicular Lymphoma
$320,633Metin Nafi Gurcan · Ohio State University · R01 · FY2009 · CA
NOVEL DEUBIQUITINATING ENZYME, UBP46, IN HEMATOPOIESIS
$320,620Scripps Research Institute · R01 · FY2001 · CA
Resistance of CML Stem Cells to Imatinib (Gleevec)
$320,589Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Resistance of CML Stem Cells to Imatinib (Gleevec)
$320,589Ravi Bhatia · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML
$320,588Neil P Shah · University Of California, San Francisco · R01 · FY2015 · CA
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
$320,588Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2015 · CA
Oncogene Cooperativity in Leukemia Stem Cells
$320,588Craig T. Jordan · University Of Rochester · R01 · FY2012 · CA
Translational Investigation of KRas & NF1 in Myeloid Leukemia
$320,588Kevin M Shannon · University Of California, San Francisco · R37 · FY2012 · CA
Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML
$320,588Neil P Shah · University Of California, San Francisco · R01 · FY2012 · CA
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
$320,588Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2016 · CA
Trafficking and Proteolysis of Notch and Other Gamma-Secretase Substrates
$320,588Mark E Fortini · Thomas Jefferson University · R01 · FY2009 · GM
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
$320,588Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2017 · CA
Adoptive T-Cell Therapy for Acute Leukemia
$320,588Edward David Ball · University Of California, San Diego · R21 · FY2010 · CA
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
$320,588Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2013 · CA
Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML
$320,588Neil P Shah · University Of California, San Francisco · R01 · FY2016 · CA